In a pivotal ruling, the High Court in London has sided with Moderna in a patent dispute against Pfizer and BioNTech over their COVID-19 vaccines. The court found that Pfizer-BioNTech’s use of mRNA technology infringed on Moderna’s patented process involving modified RNA. Despite Pfizer and BioNTech’s arguments, the court upheld Moderna’s patent validity, highlighting the innovative nature of its methods. This decision, which also addressed a second Moderna patent, could have significant implic...